Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine

Rutgeerts, 1990, Predictability of the postoperative course of Crohn's disease, Gastroenterology, 99, 956, 10.1016/0016-5085(90)90613-6 Cottone, 2003, Review article: prevention of post-surgical relapse and recurrence in Crohn's disease, Aliment Pharmacol Ther, 17, 38, 10.1046/j.1365-2036.17.s2.12.x Borley, 1997, Preventing postoperative recurrence of Crohn's disease, Br J Surg, 84, 1493, 10.1002/bjs.1800841104 Lémann, 2006, Review article: can post-operative recurrence in Crohn's disease be prevented?, Aliment Pharmacol Ther, 24, 22, 10.1111/j.1365-2036.2006.03055.x Caprilli, 1994, Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC), Aliment Pharmacol Ther, 8, 35, 10.1111/j.1365-2036.1994.tb00158.x McLeod, 1995, Prophylactic mesalazine treatment decreases postoperative recurrence of Crohn's disease, Gastroenterology, 109, 404, 10.1016/0016-5085(95)90327-5 Brignola, 1995, Mesalazine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group, Gastroenterology, 108, 345, 10.1016/0016-5085(95)90059-4 Sutherland, 1997, A randomized, placebo-controlled, double-blind trial of mesalazine in the maintenance of remission of Crohn's disease. The Canadian Mesalazine for Remission of Crohn's Disease Study Group, Gastroenterology, 112, 1069, 10.1016/S0016-5085(97)70117-3 Lochs, 2000, Prophylaxis of postoperative relapse in Crohn's disease with mesalazine: European Cooperative Crohn's Disease Study VI, Gastroenterology, 118, 264, 10.1016/S0016-5085(00)70208-3 Cammà, 1997, Mesalazine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables, Gastroenterology, 113, 1465, 10.1053/gast.1997.v113.pm9352848 Cottone, 2000, Mesalazine and relapse prevention in Crohn's disease, Gastroenterology, 119, A, 10.1053/gast.2000.16153 Cammà, 2002, Mesalazine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a meta-analysis, Dig Liver Dis, 34, A, 10.1016/S1590-8658(02)90327-0 Rutgeerts, 1995, Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection, Gastroenterology, 108, 1617, 10.1016/0016-5085(95)90121-3 Rutgeerts, 2005, Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial, Gastroenterology, 128, 856, 10.1053/j.gastro.2005.01.010 Ewe, 1999, Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group, Eur J Gastroenterol Hepatol, 11, 277, 10.1097/00042737-199903000-00011 Hellers, 1999, Oral budesonide for prevention of post-surgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group, Gastroenterology, 116, 294, 10.1016/S0016-5085(99)70125-3 Papi, 2000, Budesonide in the treatment of Crohn's disease: a meta-analysis, Aliment Pharmacol Ther, 14, 1419, 10.1046/j.1365-2036.2000.00867.x Hanauer, 2004, Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalazine, or placebo: a 2-year trial, Gastroenterology, 127, 723, 10.1053/j.gastro.2004.06.002 Ardizzone, 2004, Azathioprine and mesalazine for prevention of relapse after conservative surgery for Crohn's disease, Gastroenterology, 127, 730, 10.1053/j.gastro.2004.06.051 Colombel, 2001, Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease, Gut, 49, 42, 10.1136/gut.49.1.42 Prantera, 2002, Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG, Gut, 51, 405, 10.1136/gut.51.3.405 Marteau, 2006, Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial, Gut, 55, 842, 10.1136/gut.2005.076604 Van Gossum, 2007, Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection, Inflamm Bowel Dis, 13, 135, 10.1002/ibd.20063 Caprilli, 2003, Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial, Aliment Pharmacol Ther, 17, 517, 10.1046/j.1365-2036.2003.01462.x Steinhart, 2007, Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease, Aliment Pharmacol Ther, 25, 1389, 10.1111/j.1365-2036.2007.03324.x Carter, 2000, IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults, Gut, 53, v1 Caprilli, 2006, European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations, Gut, 55, i36, 10.1136/gut.2005.081950c Hanauer, 2001, Management of Crohn's disease in adults, Am J Gastroenterol, 96, 635, 10.1111/j.1572-0241.2001.03671.x Rutgeerts, 2002, Crohn's disease recurrence can be prevented after ileal resection, Gut, 51, 152, 10.1136/gut.51.2.152 Rampton, 2002, Crohn's disease recurrence can be prevented after ileal resection, Gut, 51, 152, 10.1136/gut.51.2.153 Cullen, 2007, Long-term clinical results of ileocecal resection for Crohn's disease, Inflamm Bowel Dis, 13, 1369, 10.1002/ibd.20220